Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocuris is a drug discovery and development company headquartered in Bengaluru, India, specializing in the creation of novel small molecule therapeutics. The company focuses on high-impact therapeutic areas, primarily oncology and inflammatory diseases, utilizing a proprietary discovery engine that integrates computational chemistry and biological screening. Biocuris aims to develop best-in-class and first-in-class drugs by targeting specific molecular pathways such as kinases and epigenetic regulators. Their current pipeline consists of several programs in the lead optimization and preclinical stages, designed to overcome resistance and improve safety profiles compared to existing treatments. The leadership team brings extensive experience from global pharmaceutical organizations, driving the company's mission to address significant unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocuris Pharma.